2422 related articles for article (PubMed ID: 17072521)
1. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
2. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
[TBL] [Abstract][Full Text] [Related]
3. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
5. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
[TBL] [Abstract][Full Text] [Related]
6. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
8. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
9. Surgery for convexity meningiomas.
Morokoff AP; Zauberman J; Black PM
Neurosurgery; 2008 Sep; 63(3):427-33; discussion 433-4. PubMed ID: 18812953
[TBL] [Abstract][Full Text] [Related]
10. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
11. Relationship between malignant subtypes of meningioma and clinical outcome.
Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
[TBL] [Abstract][Full Text] [Related]
12. The selection of the optimal therapeutic strategy for petroclival meningiomas.
Park CK; Jung HW; Kim JE; Paek SH; Kim DG
Surg Neurol; 2006 Aug; 66(2):160-5; discussion 165-6. PubMed ID: 16876612
[TBL] [Abstract][Full Text] [Related]
13. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
Pasquier D; Bijmolt S; Veninga T; Rezvoy N; Villa S; Krengli M; Weber DC; Baumert BG; Canyilmaz E; Yalman D; Szutowicz E; Tzuk-Shina T; Mirimanoff RO;
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1388-93. PubMed ID: 18294779
[TBL] [Abstract][Full Text] [Related]
14. Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature.
Thompson LD; Bouffard JP; Sandberg GD; Mena H
Mod Pathol; 2003 Mar; 16(3):236-45. PubMed ID: 12640104
[TBL] [Abstract][Full Text] [Related]
15. Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach.
Pepper JP; Hecht SL; Gebarski SS; Lin EM; Sullivan SE; Marentette LJ
Laryngoscope; 2011 Nov; 121(11):2282-9. PubMed ID: 21994142
[TBL] [Abstract][Full Text] [Related]
16. Treatment of atypical meningioma.
Jo K; Park HJ; Nam DH; Lee JI; Kong DS; Park K; Kim JH
J Clin Neurosci; 2010 Nov; 17(11):1362-6. PubMed ID: 20800497
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution.
Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):858-63. PubMed ID: 17379447
[TBL] [Abstract][Full Text] [Related]
18. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
[TBL] [Abstract][Full Text] [Related]
19. [Role of radiotherapy in the treatment of meningioma].
Haie-Meder C; Brunel P; Cioloca C; Meder JF; Borel C; Marsiglia H; Parker F; Schlienger M
Bull Cancer Radiother; 1995; 82(1):35-9. PubMed ID: 7702938
[TBL] [Abstract][Full Text] [Related]
20. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
